Anatabine dicitrate

• CAT Number: I045995
• Molecular Formula: C22H28N2O14
• Molecular Weight: 544.46
• Purity: ≥95%
• Synonyms: 2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(2S)-1,2,3,6-tetrahydropyridin-2-yl]pyridine
• InChI: InChI=1S/C10H12N2.2C6H8O7/c1-2-7-12-10(5-1)9-4-3-6-11-8-9;2*7-3(8)1-6(13,5(11)12)2-4(9)10/h1-4,6,8,10,12H,5,7H2;2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t10-;;/m0../s1
• InChIKey: CGVRSINYLOUBAU-XRIOVQLTSA-N
• SMILES: C1C=CCNC1C2=CN=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

Anatabine dicitrate(CAT: I045995) is a small-molecule alkaloid salt derived from anatabine, a naturally occurring compound in the Solanaceae (nightshade) family. It functions as a modulator of inflammatory signaling and has been investigated for its effects on STAT3, NF-κB, and other immune-related pathways. Anatabine dicitrate has shown potential in research targeting autoimmune disorders, neuroinflammation, and thyroid disease, as well as in models of chronic inflammation. The citrate salt form improves solubility and handling, making it suitable for biological assays, mechanistic studies, and preclinical evaluation. Anatabine dicitrate serves as a valuable research tool for exploring inflammation-driven disease mechanisms.